What is NDC 87069-726?

87069-726 is the product NDC for Leukotrap WB system - CP2D, Dextrose, Unspecified form 3.21 g/63mL solution, listed with the FDA by GVS TM INC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Leukotrap WB system - CP2D (CP2D/AS-3 Anticoagulant and Additive System).

GVS TM INC, NDC labeler code 87069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Leukotrap WB system - CP2D?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Leukotrap WB system - CP2D NDC 87069-726

NDC codes

FDA NDC Directory

Product NDC (as listed)87069-726Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87069-0726Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
87069-726-62	87069072662	6 POUCH in 1 CARTON (87069-726-62) / 3 BAG in 1 POUCH / 63 mL in 1 BAGMarketed from Jun 2, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Leukotrap WB system - CP2D
Generic name (nonproprietary): cp2d/as-3 anticoagulant and additive system
Active ingredients: Dextrose, Unspecified form — 3.21 g/63mL
Dosage form: Solution
Route: Intravenous
Labeler: GVS TM INCNDC labeler code 87069
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 820915
Marketing start: Jun 2, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 87069-726_55b57873-3c3e-0ce2-e063-6294a90aa6ceSPL ID 55b57873-3c3e-0ce2-e063-6294a90aa6ceSPL set ID 42ece7e1-1da1-7e5a-e063-6294a90ac803UNII IY9XDZ35W2

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N487069072662 followed by a unit qualifier and the quantity

Package 87069-0726-62. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2026.

Full label on DailyMed (opens in a new tab)

About NDC 87069-726

What is NDC 87069-726?: 87069-726 is the product NDC for Leukotrap WB system - CP2D, Dextrose, Unspecified form 3.21 g/63mL solution, listed with the FDA by GVS TM INC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Leukotrap WB system - CP2D (CP2D/AS-3 Anticoagulant and Additive System).
What is the active ingredient?: Dextrose, Unspecified form.
Who is the labeler?: GVS TM INC, NDC labeler code 87069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Leukotrap WB system - CP2D?: 1 other product NDC are listed under this name. See all Leukotrap WB system - CP2D NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Leukotrap WB system - CP2D NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive system	Dextrose, Unspecified form 3.57 g/70mL	SolutionIntravenous	GVS TM INC	87069-126	87069-0126-63

Other NDCs under BN 820915

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BN 820915
Product	Strength	Form · route	Labeler	Product NDC
As-3	Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL	SolutionIntravenous	GVS TM INC	87069-460
As-3	Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mL	SolutionIntravenous	GVS TM INC	87069-462
Blood Collection Systemcp2d/as-3 triple with sampling system	Dextrose, Unspecified form 3.57 g/70mL	SolutionIntravenous	GVS TM INC	87069-121
Cp2D	Dextrose, Unspecified form 4.64 g/100mL	SolutionIntravenous	GVS TM INC	87069-455
Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive system	Dextrose, Unspecified form 3.57 g/70mL	SolutionIntravenous	GVS TM INC	87069-123
Leukotrap RC Systemcp2d/as-3 anticoagulant and additive system	Dextrose, Unspecified form 3.57 g/70mL	SolutionIntravenous	GVS TM INC	87069-129
Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive system	Dextrose, Unspecified form 3.57 g/70mL	SolutionIntravenous	GVS TM INC	87069-126